Dana-Farber Cancer Institute

https://www.dfci.harvard.edu

From achieving the first remissions in childhood cancer with chemotherapy in 1948, to developing the very latest new therapies, Dana-Farber Cancer Institute is one of the world's leading centers of cancer research and treatment. It is the only center ranked in the top 4 of U.S. News and World Report's Best Hospitals for both adult and pediatric cancer care. Dana-Farber sits at the center of a wide range of collaborative efforts to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber/Brigham and Women's Cancer Center provides the latest in cancer care for adults; Dana-Farber/Boston Children's Cancer and Blood Disorders Center for children. The Dana-Farber/Harvard Cancer Center unites the cancer research efforts of five Harvard academic medical centers and two graduate schools, while Dana-Farber Community Cancer Care provides high quality cancer treatment in communities outside Boston's Longwood Medical Area. Dana-Farber is dedicated to a unique, 50/50 balance between cancer research and care, and much of the Institute's work is dedicated to translating the results of its discovery into new treatments for patients locally and around the world. *

	Start	1947-01-01 established
	Group	Harvard University
	Industry	medicine

	Street	450 Brookline Avenue
	City	02215 Boston, MA
	Tel	+1-617-632-3000
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Deerfield Management Company L.P.. (11/13/18). "Press Release: Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Center for Protein Degradation". Boston, MA & New York, NY.

		Record changed: 2020-01-03